# Phase 1 Quality Review

## Scope and method

- **Sources reviewed:** `input/brd.md`, `workflow/phase-1-discover.md`, `workflow/run-phase-01.md`, `skills/persona-synthesis-skill.md`, `agents/agent-01.md`, `agents/agent-02.md`, `agents/agent-03.md`, `gates/gate-01-review.md`, `outputs/phase-01/persona.md`, and `outputs/phase-01/pain-points.md`.
- **Method:** Manually applied Agent 03's review criteria and the Phase 1 validation criteria, with structural and BRD-section reference checks. No separate agent instance was launched; this is an assistant-performed quality review, not independent human approval.
- **Scope limitation:** This checks document consistency against the BRD. It does not validate the BRD's working hypotheses with users, verify live data or integrations, or grant business approval.

## Findings

| Check | Result | Evidence / observation | Required action |
|---|---|---|---|
| Persona role relevance and required structure | PASS | Five role-based profiles are present: underwriter, underwriting assistant/intake specialist, underwriting manager, product owner/system administrator, and broker/agent as an indirect stakeholder. All five include the ten required fields from the persona skill. | None identified by this check. |
| Persona confidence, source evidence, and review guidance | PASS | 74 material confidence labels are present (52 HIGH, 10 MEDIUM, 12 LOW); each labeled insight line includes evidence and review guidance. The content distinguishes BRD-based synthesis and proposed workflows from validated research. | Preserve the existing persona file; no correction was needed in this review. |
| Persona traceability and boundaries | PASS | Cited role, needs, feature, scenario, risk, and functional-requirement references correspond to BRD sections. The broker remains indirect, and material underwriting decisions remain with authorized professionals. | None identified by this check. |
| Pain-point output completeness | PASS | Ten distinct entries are present. Each includes a pain point or need, affected users, workflow context/consequence, evidence status, and assumptions/questions. Each material insight has a confidence label, BRD evidence, and review guidance. | None identified by this check. |
| Pain-point confidence and source traceability | PASS | The output uses HIGH for stated source content, MEDIUM for identified inferences, and LOW for unknowns/assumptions. The 19 unique BRD section references checked against the source are present. No direct-conflict claim is mislabeled as an ordinary inference. | None identified by this check. |
| Hypotheses, proposed behavior, and unsupported findings | PASS | §2 pain statements are retained as working hypotheses. Proposed features and scenarios are not described as implemented or observed behavior. No interviews, demographics, frequency estimates, time savings, or operational measurements were introduced. | Human discovery validation remains necessary before treating hypotheses as findings. |
| Contradictions and decision authority | PASS | No material contradictory requirement or user statement was identified in the reviewed BRD. The chatbot-first direction and continued direct navigation are treated as compatible constraints. Human verification, authorized access, and external-action safeguards are preserved. | Recheck if source content changes; human review must resolve any future conflict. |
| Overall document validation | PASS — READY FOR HUMAN GATE REVIEW | Both output documents meet the applicable structural, evidence, confidence, traceability, and uncertainty checks performed for this run. | Proceed to Gate 01 human review; do not proceed to Phase 2 until explicit approval is recorded. |

## Open items for human review

- Confirm the role distinctions and release-scope fit of both documents.
- Validate the §2 working hypotheses with underwriters, intake specialists, and relevant stakeholders before treating them as confirmed user findings.
- Confirm the assumptions and open questions in the pain-point inventory, including actual workflows, checklists, data availability, status definitions, and administrative ownership.
- Review any remaining uncertainty or business-impact priority; this report does not assign business priority.

## Gate status

**Gate 01 decision: AWAITING HUMAN REVIEW.** No `APPROVED` or `REVISION REQUIRED` decision is made in this quality report. The authorized reviewer must apply `gates/gate-01-review.md` and record the actual decision in `outputs/reviews/gate-01-review-record.md` (or the established review-record path). Phase 2 remains blocked until an explicit human `APPROVED` decision is recorded for the reviewed artifact versions.
